Industry consultant Michael Drues will discuss how medical device companies can better prepare for FDA inspections.

AI can accelerate drug discovery, clinical development, and patient access, but regulatory hurdles remain. Anders Romare, ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Glassdoor's annual Employees’ Choice Awards honor the Best Places to Work 2026 across the U.S. and the UK. Here's which ...

Make it stop. Ozempic's maker has taken the warehouse of cash it has made to reunite the "I'm a Mac" actors for another ...

Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

As noted previously, when Veeva ended its licence agreement with Salesforce, it not only triggered a battle royale for ...

Momentum around the talks has picked up after European Commission President said EU was working to deepen its strategic and ...

Leaders from medical marketing shops like AbelsonTaylor Group, Merge and Citrus Health weigh in on Omnicom’s impact on the Chicago ad scene.

Corvus Pharmaceuticals, Inc. shares are up on solid soquelitinib AD phase 1 data: 75% hit EASI 75 at 200 mg BID, many benefits, broad upside. Click for this CRVS update.

In 2026, the spotlight will be on a handful of therapeutic strategies that could change cancer care for patients by offering ...

Researchers from the Institute for Advanced Chemistry of Catalonia (IQAC) of the Spanish National Research Council (CSIC) ...